68

Shanghai Allist Pharmaceuticals Co LtdSHG 688578 Stock Report

Last reporting period 31 Dec, 2022

Updated 22 Oct, 2024

Last price

Market cap $B

2.056

Small

Exchange

XSHG - Shanghai Stock Exchange

688578.SS Stock Analysis

68

Uncovered

Shanghai Allist Pharmaceuticals Co Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

2.056

Dividend yield

1.38 %

Shares outstanding

450 B

Shanghai Allist Pharmaceuticals Co Ltd is a China-based company focusing on the field of tumor treatment. The Company has built a research and development pipeline in the field of small molecule targeted drugs for non-small cell lung cancer. The Company has established a complete new drug research and development system, covering all aspects of lead drug discovery and optimization, candidate drug evaluation and establishment, drug preclinical and clinical research, drug registration and application, industrialization and commercialization. The Company has a number of research pipeline projects under development, such as vometinib. Its drugs are used in the fields of blood pressure reduction, anti-tumor, anti-diabetic and gastric acid related diseases.

View Section: Eyestock Rating